Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Type I interferon response against viral and non-viral gene transfer in human tumor and primary cell lines.
Rautsi O, Lehmusvaara S, Salonen T, Häkkinen K, Sillanpää M, Hakkarainen T, Heikkinen S, Vähäkangas E, Ylä-Herttuala S, Hinkkanen A, Julkunen I, Wahlfors J, Pellinen R. Rautsi O, et al. Among authors: lehmusvaara s. J Gene Med. 2007 Feb;9(2):122-35. doi: 10.1002/jgm.997. J Gene Med. 2007. PMID: 17191255
Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy.
Rautsi O, Lehmusvaara S, Ketola A, Määttä AM, Wahlfors J, Pellinen R. Rautsi O, et al. Among authors: lehmusvaara s. Cancer Gene Ther. 2008 May;15(5):303-14. doi: 10.1038/cgt.2008.17. Epub 2008 Feb 29. Cancer Gene Ther. 2008. PMID: 18309353
miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer.
Rauhala HE, Jalava SE, Isotalo J, Bracken H, Lehmusvaara S, Tammela TL, Oja H, Visakorpi T. Rauhala HE, et al. Among authors: lehmusvaara s. Int J Cancer. 2010 Sep 1;127(6):1363-72. doi: 10.1002/ijc.25162. Int J Cancer. 2010. PMID: 20073067 Free article.
Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.
Lehmusvaara S, Erkkilä T, Urbanucci A, Jalava S, Seppälä J, Kaipia A, Kujala P, Lähdesmäki H, Tammela TL, Visakorpi T. Lehmusvaara S, et al. Prostate. 2013 Jan;73(1):101-12. doi: 10.1002/pros.22545. Epub 2012 Jun 5. Prostate. 2013. PMID: 22674191 Clinical Trial.
Chemical castration and anti-androgens induce differential gene expression in prostate cancer.
Lehmusvaara S, Erkkilä T, Urbanucci A, Waltering K, Seppälä J, Larjo A, Tuominen VJ, Isola J, Kujala P, Lähdesmäki H, Kaipia A, Tammela TLj, Visakorpi T. Lehmusvaara S, et al. J Pathol. 2012 Jul;227(3):336-45. doi: 10.1002/path.4027. Epub 2012 May 8. J Pathol. 2012. PMID: 22431170 Clinical Trial.
Probabilistic analysis of gene expression measurements from heterogeneous tissues.
Erkkilä T, Lehmusvaara S, Ruusuvuori P, Visakorpi T, Shmulevich I, Lähdesmäki H. Erkkilä T, et al. Among authors: lehmusvaara s. Bioinformatics. 2010 Oct 15;26(20):2571-7. doi: 10.1093/bioinformatics/btq406. Epub 2010 Jul 14. Bioinformatics. 2010. PMID: 20631160 Free PMC article.
Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis.
Bruchmann A, Roller C, Walther TV, Schäfer G, Lehmusvaara S, Visakorpi T, Klocker H, Cato AC, Maddalo D. Bruchmann A, et al. Among authors: lehmusvaara s. BMC Cancer. 2013 Mar 1;13:96. doi: 10.1186/1471-2407-13-96. BMC Cancer. 2013. PMID: 23448667 Free PMC article.